Ivemend 150 mg, Infusionspräparat

7680579130037 CH-57913 Infusionspräparat
Ivemend 150 mg, Infusionspräparat
Ivemend 150 mg, Infusionspräparat
Ivemend 150 mg, Infusionspräparat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionspräparat
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/09/2025
Summary of Product Characteristics
Français
18/09/2025
Summary of Product Characteristics
Italien
18/09/2025

Detailed composition

Substance Quantity Type Category
PRC
150.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance WIZUS
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
1.89 MG Substance HBESI

Reimbursement information

Public price
CHF 79.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2014

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
57913
Drug name
Ivemend, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULVI
ATC Code
A04AD12
Authorization status
Z
Dispensing category
B
First authorization
03/07/2008
Authorization expiration date
31/12/9999
IT Number
01.09.0.
Domain
Human medicine
Field of application
Antiemetikum

Package details

Description (FR)
IVEMEND subst seche 150 mg 1 pce
Description (DE)
IVEMEND Trockensub 150 mg 1 Stk
Market launch
14/03/2011
Narcotic (BTM)
No

Other package sizes (2)

IVEMEND subst sèche 115 mg flac
1 DUR
GTIN: 7680579130013
Not in V1
IVEMEND subst sèche 115 mg flac 10 pce
10 DUR
GTIN: 7680579130020
Not in V1